Crossmark

Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/S13018-021-02554-8

Published: 2021-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Jiang, Lianghai

Cui, Xianghua

Ma, Haoning

Tang, Xiangsheng http://orcid.org/0000-0003-4634-1014
License Information

Text and Data Mining valid from 2021-06-22

Version of Record valid from 2021-06-22
More Information

Article History

Received: 3 February 2021

Accepted: 11 June 2021

First Online: 22 June 2021

Declarations

:

: Not applicable.

: Consent for publication was obtained from the participant.

: All authors declare no competing interests.

Document is current

Any future updates will be listed below